Acrivastine

From Self-sufficiency
Jump to: navigation, search
Acrivastine
File:Acrivastine.svg
Systematic (IUPAC) name
(E)-3-{6-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-yl-
prop-1-enyl]pyridin-2-yl}prop-2-enoic acid
Clinical data
Pregnancy
category
  • US: B (No risk in non-human studies)
Routes of
administration
oral
Legal status
Legal status
Pharmacokinetic data
Biological half-life 1.5 hours
Excretion Renal
Identifiers
CAS Number 87848-99-5
ATC code R06AX18 (WHO)
PubChem CID 5284514
ChemSpider 4447574
Chemical data
Formula C22H24N2O2
Molar mass 348.438 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Acrivastine is a medication used for the treatment of allergies and hay fever. It is a second-generation H1-receptor antagonist antihistamine and works by blocking Histamine H1 receptors.

It is sold under the brand name Benadryl Allergy Relief in the U.K. by Pfizer, not to be confused with Benadryl Once a Day, which is cetirizine and is also sold by Pfizer in the U.K. This drug is currently not available as a generic in the U.K.[1]

In the U.S., acrivastine is the active ingredient in the Semprex-D brand. Semprex-D is also acrivastine-based, but contains a decongestant, pseudoephedrine. Semprex-D is marketed in the U.S. by UCB, Inc..[2][3]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />


da:Acrivastin sk:Acrivastin
  1. Cheapest hayfever remedies 2007, Money Saving expert, May 15, 2007
  2. Products - United States UCB
  3. SEMPREX-D - acrivastine and pseudoephedrine hydrochloride capsule U.S. National Library of Medicine, National Institutes of Health, May 2008